You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Embolism and thrombosis

Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation

  • Technology appraisal guidance
  • Reference number: TA249
  • Published:  15 March 2012
  • Last updated:  02 July 2021
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Atrial fibrillation - dabigatran etexilate: appeal decision

Atrial fibrillation - dabigatran etexilate: appeal decision Atrial fibrillation - dabigatran etexilate: appeal decision
13 March 2012
(170.39 Kb 49 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 13 March 2012

Back to top